Audience
Illustrators or comic artists looking for a cross-platform application to draw and create illustrations anywhere
About MediBang Paint
MediBang Inc is a software developer and digital publisher that provides artists with the tools they need to turn their mobile devices into digital canvases for free. We provide software and apps that anyone from professional to hobbyist can use while providing a platform for them to share their work worldwide. MediBang Paint is a free program with which you can draw and create spectacular digital comics, since, among other resources, it has a large number of brushes, fonts and predetermined backgrounds. MediBang is available for Windows, Mac OS X, Android, and iOS. This application uses cloud storage, so you can seamlessly transfer your creations between different platforms. The Android version allows you to draw and create illustrations anywhere with all the functions of the PC version. MediBang Paint has many creative tools for illustrators and comic artists, such as numerous brushes, textures, backgrounds and fonts that you can easily download from the cloud.
Pricing
Integrations
Company Information
Product Details
MediBang Paint Frequently Asked Questions
MediBang Paint Product Features
MediBang Paint Additional Categories
MediBang Paint Verified User Reviews
Write a Review-
Probability You Would Recommend?1 2 3 4 5 6 7 8 9 10
"MediBang Pro Paint " Posted 2022-01-30
Pros: It has a very customizable and interactive interface and I like the dark theme, it doesn't strain your eyes at all. It's very easy to use and has a variety of brushes. It's a great free program and very beginner-friendly.
Cons: Because it's beginner-friendly, it doesn't have many advanced features. Customizing and creating new brushes can be difficult and you can only add new brushes from the app's collection.
Overall: Overall it's a great program and it's available on all platforms. I'd highly suggest it to new artists or people who want to experiment with their art style.
Read More...
- Previous
- You're on page 1
- Next